Dvia Centaur Insulin Assays (2017-04-10)

Advia Centaur Insulin Assays Recall Siemens Healthcare Diagnostics is recalling Advia Centaur Insulin Assays used in hospitals and laboratories across Canada. The assays, which measure insulin levels in blood samples, were recalled because they are classified as medical devices requiring regulatory approval. This recall affects healthcare facilities nationwide that use these testing kits.

Reason

Medical devices

Classification

Class I

Category

drug recall

Country

Canada

Agency

HC-DEVICES

Recall date

2017-05-02

Status

Closed

Distribution

Canada-wide

Official recall notice from HC-DEVICES

Recall details on Nibble Recalls: https://trynibble.app/recalls/afc57309-d116-457b-9b53-b8ca7a7142ea